Headlines

This week, a liquid nose job leads to lasting eye pain, service animals receive free eye screens and 3D-printed corneas could shave years off keratoplasty wait times.

This week, a retired competitive agility dog dons prescription eyewear, botulism toxin becomes a first-line treatment for blepharospasm and GenSight’s experimental gene therapy for Leber's neuropathy shows sustained benefits at 2 years.

From pterygium surgery tips to dangerous wineglasses, here’s a look at the year’s most-viewed interviews, surgical videos and 1-Minute Videos.

Due to lack of sterility assurance, the FDA is urging healthcare professionals not to use sterile drug products produced and distributed by Ranier’s Compounding Laboratory, Ranier’s Pharmacy and Ranier’s RX Laboratory, Jeannette, Pennsylvania.

This week a crescent-shaped burn highlights the need for protective eyewear during solar eclipses, and fungal infections fall prey to a rose-colored eyedrop combined with green fluorescent light.

Whether you plan to take the Demonstration of Ophthalmic Cognitive Knowledge (DOCK) exam or participate in the new ABO Quarterly Questions pilot program, the Academy has the tools you'll need to ensure success.

Allergan, Inc., reported $1.6 billion in total product net sales for the quarter ended March 31, an increase of 13 percent compared to the first quarter of 2013.

The FDA issued a reminder to health care providers not to administer any sterile products made and distributed by NuVision Pharmacy of Dallas because their sterility is not assured. This alert follows the FDA’s notice on May 18 recommending that health care providers…

The FDA has announced a voluntary nationwide recall of all sterile use products produced and distributed by a Texas compounding pharmacy, Specialty Compounding in Cedar Park, Texas. The pharmacy is responding to reports of bacterial bloodstream infections potentially related…

Merck & Co, Inc., reported worldwide sales of $11.0 billion for the second quarter of 2013, a drop of 11 percent compared with the quarter a year earlier. The company said the decline in sales was due to patents expiring and a negative impact of foreign exchange rates.…

STAAR Surgical Co. reported revenues of $18.2 million for the second quarter ended June 28, an increase of 14 percent over the second quarter of 2012. The results included sales of $11.3 million for the company's Visian ICL product portfolio and $5.9 million for its IOL prod…